Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2017

View Archived Issues

XyloCor Therapeutics' XC-001 awarded FDA fast track designation

Rasna Therapeutics provides update on RASP-101

FDA approves Kisqali Femara Co-Pack

resTORbio initiates phase IIb study of RTB-101 to reduce respiratory tract infections in the elderly

Pfizer reviews key developments of first quarter 2017

PaxVax initiates clinical trial program for modernized Ad 4/7 vaccine

FDA authorizes IND application for NANT cancer vaccine clinical trials

RET kinase inhibitor GSK-589 shows promise for IBS treatment

Auris Medical reports results from extension study of AM-101 for tinnitus

STRATOS 1 trial of tralokinumab in severe asthma does not meet primary endpoint

Corvus Pharmaceuticals enters immuno-oncology agreement with Monash University

Apellis Pharmaceuticals granted E.U. orphan drug designation for APL-2 in PNH

FDA approves Bavencio for advanced urothelial carcinoma

Array reports part 2 data from COLUMBUS study of binimetinib and encorafenib in advanced melanoma

Pharnext and Tasly enter strategic agreement

Recro Pharma reports positive topline data from phase III study of intravenous meloxicam

FDA grants orphan drug designation to XmAB-5871

FORUM Pharmaceuticals discovers novel nicotinic alpha7 receptor agonists

TXP Pharma identifies new N-formyl peptide receptor 2 agonists

Novel compounds for parasitic protozoal infections discovered at GlaxoSmithKline

Selvita divulges new MKNK1/MKNK2 inhibitors

Merck & Co. describes novel antituberculosis compounds

Redx Pharma presents data for REDX-08106 as a potent antibacterial compound

IMvigor211 study of Tecentriq in advanced bladder cancer does not meet primary endpoint

Universite de Montreal discloses novel proteinase-activated receptor 4 antagonists

CD26, a marker of hepatic inflammation in hepatitis E virus infection

Clinical benefit seen with upadacitinib tartrate in Crohn's disease patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.